ipamorelin vs cjc-1295

ipamorelin (C-tier) vs cjc-1295 (A-tier). mechanism, trials, evidence boundaries, dosing literature. side-by-side reference.

ipamorelin · tier C

Ipamorelin is a synthetic pentapeptide ghrelin-receptor agonist. People seek it for sleep, recovery, and body composition, but direct human studies measured an acute intravenous GH pulse and a negative ileus outcome.

Ipamorelin released GH after intravenous infusion, but it has no controlled human sleep, recovery, muscle, or body-composition outcome trial. Its selectivity case comes mainly from swine and rodent work.

114 patients in the negative ileus trial · half-life about 2 hours after intravenous infusion · growth hormone

cjc-1295 · tier A

growth hormone without injecting growth hormone. tells your pituitary to make its own. paired with ipamorelin.

tells the pituitary to make its own GH through the GHRH receptor. paired with ipamorelin. DAC vs no-DAC is the live argument.

PCAC '24 503A excluded · half-life ~6-8 days (with DAC); ~30 min (no DAC / Mod GRF 1-29) · growth hormone

at a glance

• ipamorelin: tier C · 114 patients in the negative ileus trial
• cjc-1295: tier A · PCAC '24 503A excluded

reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.